Date | Price Target | Rating | Analyst |
---|---|---|---|
4/10/2024 | Overweight → Sector Weight | KeyBanc Capital Markets | |
1/3/2024 | $14.00 | Overweight | Barclays |
1/3/2024 | $11.00 | In-line → Outperform | Evercore ISI |
12/13/2023 | $14.00 → $11.00 | Neutral → Overweight | JP Morgan |
11/13/2023 | $12.00 → $11.00 | Neutral → Overweight | Piper Sandler |
8/1/2023 | $16.00 | Overweight | Cantor Fitzgerald |
5/10/2023 | Outperform → Mkt Perform | Raymond James | |
5/10/2023 | Buy → Neutral | Guggenheim |
4 - Health Catalyst, Inc. (0001636422) (Issuer)
4 - Health Catalyst, Inc. (0001636422) (Issuer)
4 - Health Catalyst, Inc. (0001636422) (Issuer)
KeyBanc Capital Markets downgraded Health Catalyst from Overweight to Sector Weight
Barclays initiated coverage of Health Catalyst with a rating of Overweight and set a new price target of $14.00
Evercore ISI upgraded Health Catalyst from In-line to Outperform and set a new price target of $11.00
D - Health Catalyst, Inc. (0001636422) (Filer)
10-Q - Health Catalyst, Inc. (0001636422) (Filer)
8-K - Health Catalyst, Inc. (0001636422) (Filer)
SALT LAKE CITY, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ((", Health Catalyst", , NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Dan Burton, Chief Executive Officer, Jason Alger, Chief Financial Officer, Dan LeSueur, Chief Operating Officer, and Jack Knight, Vice President of Investor Relations, will participate in the following upcoming investor conferences: The Wells Fargo Healthcare Conference, being held in Boston, including a fireside chat on Wednesday, September 4, 2024, at 1:30pm ET. The webcast link and related presentation materials will be available online at https://ir.healthcatalys
SALT LAKE CITY, Aug. 27, 2024 /PRNewswire/ -- Health Catalyst, Inc. ((", Health Catalyst, ", NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Wisconsin Statewide Health Information Network, Inc. (WISHIN), an independent not-for-profit organization dedicated to bringing the benefits of widespread, secure, interoperable health information technology to patients and caregivers throughout Wisconsin, has selected to expand its multi-year agreement with Health Catalyst. The multi-year arrangement will in
SALT LAKE CITY, Aug. 8, 2024 /PRNewswire/ -- Health Catalyst, Inc. ((", Health Catalyst, ", NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced an expanded relationship with longtime client, South Dakota Health Link ("Health Link"). This renewed agreement will include an expansion of technology and services, including the migration of technology to Ninja Universe by Health Catalyst™, an end-to-end cloud-native platform and set of applications purpose-built for Health Information Exchanges (HIEs). Health Li
SC 13G/A - Health Catalyst, Inc. (0001636422) (Subject)
SC 13G/A - Health Catalyst, Inc. (0001636422) (Subject)
SC 13G - Health Catalyst, Inc. (0001636422) (Subject)
4 - Health Catalyst, Inc. (0001636422) (Issuer)
SALT LAKE CITY, June 6, 2024 /PRNewswire/ -- Health Catalyst, Inc. ((", Health Catalyst, ", NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced it has successfully completed its acquisition of Carevive Systems ("Carevive"), a leading oncology-focused health technology company centered on understanding and improving the experience of patients with cancer. Oncology providers and life science researchers use Carevive's flagship platform and/or Carevive data in routine clinical practice for treatment care plan
Dr. Jennifer Doudna, Dr. Michael Pfeffer, Gregory Robinson & More Join HAS 2024 SALT LAKE CITY, Feb. 2, 2024 /PRNewswire/ -- The Healthcare Analytics Summit (HAS), an annual interactive and educational event for the healthcare industry, today announced its keynote and session speaker lineup for the 2024 event. In its tenth year, HAS 24 is the premier event showcasing data and analytics' critical role in tackling some of healthcare's greatest challenges. HAS 24 convenes national experts whose leadership in data and analytics, machine learning, AI, and healthcare technology have
Carta Healthcare closes series B, triples revenue, and brings in seasoned health tech leader Brent Dover to accelerate growth Health tech company Carta Healthcare®, whose mission is to harness the value of clinical data, is pleased to announce the appointment of Brent Dover as chief executive officer. Dover succeeds former CEO Matt Hollingsworth who co-founded Carta Healthcare in 2017 and who remains a member of the board. In his new role, he will continue to focus on product innovation, business development, and strategic partnerships for Carta Healthcare's market-leading solutions. "I am thrilled to welcome Brent to the Carta Healthcare leadership team. While his expertise in scaling
SALT LAKE CITY, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ((", Health Catalyst, ", NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended June 30, 2024. "For the second quarter of 2024, I am pleased by our strong financial results, including total revenue of $75.9 million and Adjusted EBITDA of $7.5 million, with these results exceeding the mid-point of our quarterly guidance on each metric. I am also pleased with our bookings performance through Q2 2024, especially as it relates to our net new Platform Subscription Clients. In the first half of 2024 we signed more net
SALT LAKE CITY, July 24, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ((", Health Catalyst", , NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its second quarter 2024 operating results on Wednesday, August 7, 2024, after market close. In conjunction, the company will host a conference call to review the results at 5 p.m. E.T. on the same day. Conference Call Details The conference call can be accessed by dialing 800-267-6316 for U.S. participants, or 203-518-9783 for international participants, and referencing conference ID "HCATQ224." A live audio webcast will be available online at https://ir.healthcatalyst.com/
SALT LAKE CITY, May 09, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ((", Health Catalyst, ", NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended March 31, 2024. "For the first quarter of 2024, I am pleased by our strong financial results, including total revenue of $74.7 million and Adjusted EBITDA of $3.4 million, with these results beating the mid-point of our quarterly guidance on each metric. This financial performance demonstrates our ability to continue to scale our business as we drive toward our long-term profitability goals. We are reiterating our full year 2024 total
In the last three months, 4 analysts have published ratings on Health Catalyst (NASDAQ:HCAT), offering a diverse range of perspectives from bullish to bearish. The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 3 0 0 0 Last 30D 0 1 0 0 0 1M Ago 0 0 0 0 0 2M Ago 1 2 0 0 0 3M Ago 0 0 0 0 0 Analysts have set 12-month price targets for Health Catalyst, revealing an average target of $11.5, a high estimate of $14.00, and a low estimate of $8.00. A negative shift in sentiment is evident as a
Evercore ISI Group analyst Elizabeth Anderson maintains Health Catalyst (NASDAQ:HCAT) with a Outperform and lowers the price target from $9 to $8.
Throughout the last three months, 4 analysts have evaluated Health Catalyst (NASDAQ:HCAT), offering a diverse set of opinions from bullish to bearish. The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 3 0 0 0 Last 30D 0 1 0 0 0 1M Ago 1 1 0 0 0 2M Ago 0 1 0 0 0 3M Ago 0 0 0 0 0 In the assessment of 12-month price targets, analysts unveil insights for Health Catalyst, presenting an average target of $13.5, a high estimate of $16.00, and a low estimate of $11.00. Marking an increase of 1.28%, the